Collectively, these findings indicate that TGFβ activates NF-kB through p38 MAPK in lung cancer cells, and SC-1 inhibits TGFβ-mediated IL-6 secretion via the p38–NF-kB signaling cascade. Here, IL6 is linked to lung cancer.